Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers 2023-05-31
  2. The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease 2022-04-27

Studies

2 studies carry this tag.

Date range

2022 to 2023

Top journals

  • Alzheimer's research & therapy 1
  • International journal of molecular sciences 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's research & therapy 2023-05-31 Biomarkers

    This study tests the hypothesis that GM and mediators of the microbiota-gut-brain axis (MGBA) are associated with the amyloid cascade in sporadic AD.

  2. The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. International journal of molecular sciences 2022-04-27 Treatments

    Along with the increase in life expectancy in the populations of developed and developing countries resulting from better access and improved health care, the number of patients with dementia, including Alzheimer's disease (AD), is growing.

All topic tags with their study counts